Alzex Neuropharma Statistics
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
TRRI has 1.51 million shares outstanding.
| Current Share Class | 1.51M |
| Shares Outstanding | 1.51M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 0.01.
| PE Ratio | 0.01 |
| Forward PE | n/a |
| PS Ratio | 0.00 |
| PB Ratio | 0.00 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 0.00 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.43, with a Debt / Equity ratio of 0.60.
| Current Ratio | 1.43 |
| Quick Ratio | 1.40 |
| Debt / Equity | 0.60 |
| Debt / EBITDA | 67.41 |
| Debt / FCF | n/a |
| Interest Coverage | -6.67 |
Financial Efficiency
Return on equity (ROE) is 2.85% and return on invested capital (ROIC) is -1.86%.
| Return on Equity (ROE) | 2.85% |
| Return on Assets (ROA) | -1.64% |
| Return on Invested Capital (ROIC) | -1.86% |
| Return on Capital Employed (ROCE) | -3.25% |
| Weighted Average Cost of Capital (WACC) | 0.91% |
| Revenue Per Employee | 430,366 |
| Profits Per Employee | 2,914 |
| Employee Count | 11 |
| Asset Turnover | 2.25 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.90% in the last 52 weeks. The beta is -53.95, so TRRI's price volatility has been lower than the market average.
| Beta (5Y) | -53.95 |
| 52-Week Price Change | -99.90% |
| 50-Day Moving Average | 0.13 |
| 200-Day Moving Average | 0.29 |
| Relative Strength Index (RSI) | 42.25 |
| Average Volume (20 Days) | 2,160 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.00 |
Income Statement
In the last 12 months, TRRI had revenue of 4.73 million and earned 32,053 in profits.
| Revenue | 4.73M |
| Gross Profit | 430,143 |
| Operating Income | -55,149 |
| Pretax Income | 32,053 |
| Net Income | 32,053 |
| EBITDA | 9,232 |
| EBIT | -55,149 |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 112,836 in cash and 622,324 in debt, with a net cash position of -509,488 or -0.34 per share.
| Cash & Cash Equivalents | 112,836 |
| Total Debt | 622,324 |
| Net Cash | -509,488 |
| Net Cash Per Share | -0.34 |
| Equity (Book Value) | 1.05M |
| Book Value Per Share | n/a |
| Working Capital | 87,446 |
Cash Flow
| Operating Cash Flow | 286,416 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 9.09%, with operating and profit margins of -1.16% and 0.68%.
| Gross Margin | 9.09% |
| Operating Margin | -1.16% |
| Pretax Margin | 0.68% |
| Profit Margin | 0.68% |
| EBITDA Margin | 0.20% |
| EBIT Margin | -1.16% |
| FCF Margin | n/a |
Dividends & Yields
TRRI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 10,648.84% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 18, 2015. It was a reverse split with a ratio of 0.0033333.
| Last Split Date | Sep 18, 2015 |
| Split Type | Reverse |
| Split Ratio | 0.0033333 |
Scores
TRRI has an Altman Z-Score of 3.46 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.46 |
| Piotroski F-Score | 5 |